Eric E. Swayze
0000-0001-6430-6576
Ionis Pharmaceuticals
2 papers found
Refreshing results…
Author Correction: Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
Tau-targeting antisense oligonucleotide MAPTRx in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
Missing publications? Search for publications with a matching author name.